当前位置：首页 > 文献互助 > 互助详情

Endless possibilities and how to exploit them? What is the optimal treatment sequence?复制

用户ld1Qpub7fdQg 1小时前 12 10 已关闭

DOI: 10.1182/hematology.2025000760复制

文献链接: https://ashpublications.org/hematology/article/2025/1/636/556853/Endless-possibilities-and-how-to-exploit-them-What复制

其他信息:

出版社: American Society of Hematology
作者: Rajshekhar Chakraborty; Divaya Bhutani; Suzanne Lentzsch
全文下载地址: https://ashpublications.org/hematology/article-pdf/2025/1/636/2470174/636chakraborty.pdf

上一篇：Incisional Surgical Site Infection after Abdominal Fascial Closure with Triclosan-Coated Barbed Suture vs Triclosan-Coated Polydioxanone Loop Suture vs Polydioxanone Loop Suture in Emergent Abdominal Surgery: A Randomized Clinical Trial

下一篇：Endless possibilities and how to exploit them? What is the optimal treatment sequence?

互助时间线

2026-01-20 14:42:22 [关闭求助]

楼主用户ld1Qpub7fdQg关闭了求助

2026-01-20 14:38:07 [发起求助]

最新发布的求助

Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent 1分钟前
PCSK9 and ANGPTL3 inhibitors in homozygous familial hypercholesterolemia: A meta-analysis of randomized clinical trials 2分钟前
Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease 5分钟前
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications 5分钟前
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications 6分钟前
Residual cardiovascular risk is tracked by apolipoprotein B in coronary patients with elevated serum triglyceride levels: the ESC EORP EUROASPIRE IV survey 9分钟前
Clustered Regularly Interspaced Short Palindromic Repeats Genome Editing for Cardiovascular Disease: The Future Is Here 13分钟前
ANGPTL3/8: one target, multiple lipid disorders 14分钟前
Hypertriglyceridaemia and elevated cardiovascular risk: will ANGPTL4 inhibition address both? 16分钟前
Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia? 17分钟前
Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia: A Nonrandomized Clinical Trial 17分钟前
In vivo gene editing for lipid management: An early perspective from ANGPTL3-targeted CRISPR-Cas9 therapy 18分钟前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com